Catalyst Wire Dossier Catalyst Wire Dossier

Betibeglogene Autotemcel

· Genetix Biotherapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Betibeglogene Autotemcel, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

See pricing